A phase 2 feasibility trial of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolic events in patients with atrial fibrillation, who are unable to unwilling to take warfarin therapy

GY Lip; Lars Hvilsted Rasmussen; SB Olsson; S Zetterstrand; C Stahre; A Bylock; M Aunes Jansson; K Wåhlander

A phase 2 feasibility trial of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolic events in patients with atrial fibrillation, who are unable to unwilling to take warfarin therapy

GY Lip, Lars Hvilsted Rasmussen, SB Olsson, S Zetterstrand, C Stahre, A Bylock, M Aunes Jansson, K Wåhlander

Research output: Contribution to journal › Conference abstract in journal › Research

Original language	English
Pages (from-to)	S1129
Number of pages	1
Publication status	Published - 2009
Externally published	Yes
Event	AHA Scientific Sessions 2009 - Orlando, Florida Duration: 14 Nov 2009 → 18 Nov 2009

Conference

Conference	AHA Scientific Sessions 2009
City	Orlando, Florida
Period	14/11/2009 → 18/11/2009

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

@article{f44dca16746e4d9f9c31ebf5b36186a8,

title = "A phase 2 feasibility trial of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolic events in patients with atrial fibrillation, who are unable to unwilling to take warfarin therapy",

author = "GY Lip and Rasmussen, {Lars Hvilsted} and SB Olsson and S Zetterstrand and C Stahre and A Bylock and {Aunes Jansson}, M and K W{\aa}hlander",

note = "Udgivelsesdato: 2009 Volumne: 120; AHA Scientific Sessions 2009 ; Conference date: 14-11-2009 Through 18-11-2009",

year = "2009",

language = "English",

pages = "S1129",

}

A phase 2 feasibility trial of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolic events in patients with atrial fibrillation, who are unable to unwilling to take warfarin therapy. / Lip, GY; Rasmussen, Lars Hvilsted; Olsson, SB et al.
2009, p. S1129.

Research output: Contribution to journal › Conference abstract in journal › Research

TY - ABST

T1 - A phase 2 feasibility trial of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolic events in patients with atrial fibrillation, who are unable to unwilling to take warfarin therapy

AU - Lip, GY

AU - Rasmussen, Lars Hvilsted

AU - Olsson, SB

AU - Zetterstrand, S

AU - Stahre, C

AU - Bylock, A

AU - Aunes Jansson, M

AU - Wåhlander, K

N1 - Udgivelsesdato: 2009 Volumne: 120

PY - 2009

Y1 - 2009

M3 - Conference abstract in journal

SP - S1129

T2 - AHA Scientific Sessions 2009

Y2 - 14 November 2009 through 18 November 2009

ER -